CD44 deficiency is a consistent finding in childhood Burkitt's lymphoma and leukemia [9]

Leukemia

Volumn 21, Issue 5, 2007, Pages 1110-1113

  Attarbaschi, A ^a   Mann, G ^a   Schumich, A ^a   Konig M ^a   Pickl, W F ^b   Haas, O A ^a   Gadner, H ^a   Dworzak, M N ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; HERMES ANTIGEN; MESSENGER RNA;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; AUSTRIA; BONE MARROW CELL; BURKITT LYMPHOMA; CANCER RELAPSE; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOGENETICS; CYTOPATHOLOGY; DENSITY GRADIENT CENTRIFUGATION; DIAGNOSTIC ACCURACY; DOWN REGULATION; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; HIGH RISK PATIENT; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LETTER; METASTASIS POTENTIAL; MICROARRAY ANALYSIS; MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; SENSITIVITY ANALYSIS;

EID: 34247593847     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404608     Document Type: Letter

References (9)

1. Woessmann W, Seidemann K, Mann G, Zimmermann M, Burkhardt B, Oschlies I et al. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood 2005; 105: 948-958.
2. Busch K, Borkhardt A, Wossmann W, Reiter A, Harbott J. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis. Haematologica 2004; 89: 818-825.
3. Mussolin L, Basso K, Pillon M, d'Amore ES, Lombardi A, Luzzatto L et al. Prospective analysis of minimal bone marrow infiltration in pediatric Burkitt's lymphomas by long-distance polymerase chain reaction for t(8;14)(q24;q32). Leukemia 2003; 17: 585-589.
4. Dworzak MN, Fritsch G, Fleischer C, Printz D, Fröschl G, Buchinger P et al. Comparative phenotype mapping of normal vs malignant pediatric B-lymphopoiesis unveils leukemia-associated aberrations. Exp Hematol 1998; 26: 305-313.
5. Dworzak MN, Froschl G, Printz D, Mann G, Pötschger U, Mühlegger N et al. Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia. Blood 2002; 99: 1952-1958.
6. Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006; 354: 2419-2430.
7. Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ et al. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 2006; 354: 2431-2442.
8. Attarbaschi A, Mann G, Dworzak M, Trebo M, Urban C, Fink FM et al. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria - therapy results between 1986 and 2000. Wien Klin Wochenschr 2002; 114: 978-986.
9. Canonico B, Zamai L, Burattini S, Granger V, Mannello F, Gobbi P et al. Evaluation of leukocyte stabilisation in TransFix-treated blood samples by flow cytometry and transmission electron microscopy. J Immunol Methods 2004; 295: 67-78.